FFF Enterprises Celebrates 22 Counterfeit-Free Years
Press Release for July 09, 2010 – Download
Biopharmaceutical leader and innovator is a trail blazer in supply chain safety.
Temecula, Calif. – FFF Enterprises, Inc., the nation’s largest and most trusted distributor of plasma products, vaccines and critical-care biopharmaceuticals, is commemorating its 22nd anniversary this month. The company celebrates over two decades of counterfeit-free biopharmaceutical distribution, a significant accomplishment since the industry’s supply chain has long been vulnerable to tampering; statistics show that drug counterfeiting is disturbingly on the rise.
An industry leader, FFF serves over 80% of U.S. hospitals and supplies the nation’s leading non-acute care group purchasing organizations. With a driving dedication to patient safety at the forefront of every decision, FFF has incorporated from the bottom up what the pharmaceutical industry struggles to enact from the top down – a secure supply chain.
“We have always recognized that at the end of every business transaction there is a patient waiting for the product,” states Patrick M. Schmidt, chief executive officer, FFF Enterprises, Inc. “The commitment we’ve made to set the highest standards for product quality, safety and distribution is fueled by our company mission: helping healthcare care.”
FFF makes innovation a priority by continually finding new ways to secure the supply chain and streamline delivery models for the critical-care products and vaccines it manages. The company has developed a number of innovative technologies that have been instrumental in transforming accepted industry protocols. The company’s first-of-its-kind Verified Electronic Pedigree™ (VEP) system electronically displays the chain of custody for every product it ships, and its LotTrack™ service tracks products by lot number and provides recall notification to those affected. Another example of FFF’s quality commitment is epitomized by its specialty pharmacy subsidiary, NuFACTOR, which was established to provide IVIG, coagulation factors and vaccines directly to patients. Other innovative programs include MyFluVaccine and VaxAmerica, which have provided revolutionary approaches to vaccination, streamlining access and administration to preventive vaccines for healthcare providers and patients.
“By securing the supply chain and offering innovations in healthcare delivery models, we have helped establish improved industry safety standards,” Schmidt says. “For patients who depend on critical-care biopharmaceuticals and plasma products, these standards have a significant impact on their quality of life – that’s why we consider it a privilege to do what we do.”
About FFF Enterprises, Inc.
FFF Enterprises, Inc., a privately held corporation, is the largest and most trusted distributor of plasma products, vaccines and other biopharmaceuticals in the U.S. Founded in 1988, FFF is celebrating its 22nd year with more than a billion dollars in annual sales and a flawless safety track record. FFF’s Guaranteed Channel Integrity™ ensures that products are purchased only from the manufacturer and shipped only to healthcare providers, protecting patients and manufacturers from counterfeit risks and pricing irregularities inherent in secondary and gray market channels. FFF’s proprietary technologies, Verified Electronic Pedigree™ and Lot-Track™, provide verification of this secure channel. FFF’s MyFluVaccine (www.MyFluVaccine.com) has revolutionized the flu marketplace, offering a dedicated flu vaccine supply, delivered to customers on the date of their choosing, and offering certainty in a volatile market segment. FFF’s ability to move rapidly in a dynamically changing marketplace allows the creation of new opportunities for customers through innovative vehicles for distribution.